Zixuan Yang

Chinese Academy Of Medical Sciences And Peking Union Medical College
Beijing, 100021, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

A multicenter study of a predictive model for pathological complete response after neoadjuvant therapy in breast cancer using multimodal digital biomarkers.

A multicenter study of a predictive model for pathological complete response after neoadjuvant therapy in breast cancer using multimodal digital biomarkers.

Journal: Chinese journal of cancer research = Chung-kuo yen cheng yen chiu

Published: August 27, 2025

Dynamics of the intratumoural microbiome across malignant transformation and treatment in breast cancer.

Dynamics of the intratumoural microbiome across malignant transformation and treatment in breast cancer.

Journal: Clinical and translational medicine

Published: June 10, 2025

MCLAM: a cost-effective deep learning model for predicting recurrence risk in HR+/HER2- breast cancer-a multi-center study in a Chinese cohort.

MCLAM: a cost-effective deep learning model for predicting recurrence risk in HR+/HER2- breast cancer-a multi-center study in a Chinese cohort.

Journal: Journal of the National Cancer Center

Published: June 04, 2025

Exploring risk factors for endocrine-related immune-related adverse events: Insights from meta-analysis and Mendelian randomization.

Exploring risk factors for endocrine-related immune-related adverse events: Insights from meta-analysis and Mendelian randomization.

Journal: Human vaccines & immunotherapeutics

Published: October 08, 2024

Genetic associations of plasma proteins and breast cancer identify potential therapeutic drug candidates.

Genetic associations of plasma proteins and breast cancer identify potential therapeutic drug candidates.

Journal: Communications biology

Published: June 19, 2024

Liquid-based biomarkers in breast cancer: looking beyond the blood.

Liquid-based biomarkers in breast cancer: looking beyond the blood.

Journal: Journal of translational medicine

Published: May 23, 2023

Clinicopathologic characteristics and prognostic significance of HER2-low expression in patients with early breast cancer: A systematic review and meta-analysis.

Clinicopathologic characteristics and prognostic significance of HER2-low expression in patients with early breast cancer: A systematic review and meta-analysis.

Journal: Frontiers in oncology

Published: November 16, 2022

Prediction of HER2-positive breast cancer recurrence and metastasis risk from histopathological images and clinical information via multimodal deep learning.

Prediction of HER2-positive breast cancer recurrence and metastasis risk from histopathological images and clinical information via multimodal deep learning.

Journal: Computational and structural biotechnology journal

Published: September 22, 2021

Showing 1-8 of 8

Last Updated: 09/26/2026